SRTS Stock Analysis: Buy, Sell, or Hold?
SRTS - Sensus Healthcare, Inc
$2.78
0.07 (2.58%)
▲
5d:
-1.42%
30d:
-19.89%
90d:
-27.79%
BUY
HIGH Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When SRTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SRTS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SRTS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: SRTS is currently trading at $2.78, which is considered slightly low relative to its 30-day fair value range of $2.74 to $3.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -162.3) compared to its historical average (204.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTS is in a strong downtrend. Immediate support is located at $2.66, while resistance sits at $3.32.
Market Sentiment: SRTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.75 (+112.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTS is in a strong downtrend. Immediate support is located at $2.66, while resistance sits at $3.32.
Market Sentiment: SRTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.75 (+112.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.74 -
$3.37
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
96.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.2% below Wall St target ($5.75)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$2.74 -
$3.37
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.60
(21.5%)
Support & Resistance Levels
Support Level
$2.66
Resistance Level
$3.32
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-162.28
Wall Street Target
$5.75
(+112.2%)
Revenue Growth (YoY)
-59.3%
Earnings Growth (YoY)
433.3%
Profit Margin
-34.5%
PE vs Historical
-162.3 vs 204.1
CHEAP
Share & Embed Analysis
Last updated: June 17, 2026 11:13 AM ET
Data refreshes hourly during market hours. Next update: 12:13 PM
Data refreshes hourly during market hours. Next update: 12:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Eric Sachetta
BUY
2000 shares
2026-02-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 62 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced SRTS Option Strategies
Professional options setups generated by AI based on today's SRTS price and gamma walls.
